IceCure Medical Revenue Rises 26% to $2.6 Million in Nine Months
Revenue for the nine months ended September 30, 2026, rose from $2.1 million a year earlier. Net loss increased to $12.9 million from $10.8 million, U.S. sales grew 83% year over year, and cash and cash equivalents were approximately $8.2 million at quarter-end.
For the nine months ended September 30, 2026, revenue rose approximately 26% to $2.6M from $2.1M a year earlier, while net loss increased to $12.9M from $10.8M. U.S. sales grew 83% year over year; cash and cash equivalents were approximately $8.2M at quarter-end.Material DetailsContext by AI Analys…